Variant report

Variant	esv3340760
Chromosome Location	chr9:115849156-115851704
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 37 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:37 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs181983740	chr9:115851071-115851072	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs145422736	chr9:115851072-115851073	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs185863539	chr9:115851080-115851081	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs202078564	chr9:115851082-115851083	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs537269050	chr9:115851118-115851119	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs372950137	chr9:115851125-115851126	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs557639322	chr9:115851135-115851136	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs200409803	chr9:115851146-115851147	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs62574451	chr9:115851162-115851163	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs552936578	chr9:115851164-115851165	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs200924866	chr9:115851200-115851201	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs572796973	chr9:115851226-115851227	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs202138898	chr9:115851231-115851232	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs544979282	chr9:115851243-115851244	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs564668126	chr9:115851265-115851266	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs544417442	chr9:115851281-115851282	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs114625244	chr9:115851288-115851289	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs200461711	chr9:115851290-115851291	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs530428120	chr9:115851292-115851293	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs79341835	chr9:115851310-115851311	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs375250544	chr9:115851315-115851316	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs190518544	chr9:115851324-115851325	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs201701195	chr9:115851327-115851328	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs560832487	chr9:115851346-115851347	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs532437089	chr9:115851354-115851355	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs552581413	chr9:115851389-115851390	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs371380534	chr9:115851402-115851403	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs376026558	chr9:115851508-115851509	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs199634825	chr9:115851560-115851561	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs528237093	chr9:115851572-115851573	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs375211839	chr9:115851573-115851574	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs550803114	chr9:115851591-115851592	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs574994338	chr9:115851593-115851594	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs567420693	chr9:115851597-115851598	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs367837762	chr9:115851623-115851624	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs1819430	chr9:115851626-115851627	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs536442935	chr9:115851665-115851666	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
small cell lung cancer	20016488	CNVD
Cardiac fibroma	18329553	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Lung cancer	19147751	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	22522925	CNVD
Melanoma	20877625	CNVD
Bladder cancer	21909424	CNVD

Chromatin state (count:10 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:115851000-115851200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
2	chr9:115851000-115851400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
3	chr9:115851000-115851400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
4	chr9:115851200-115851400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr9:115851200-115851400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
6	chr9:115851200-115851400	Bivalent Enhancer	Fetal Stomach	stomach
7	chr9:115851200-115851400	Bivalent Enhancer	Ovary	ovary
8	chr9:115851200-115851400	Enhancers	Pancreas	Pancrea
9	chr9:115851200-115851400	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
10	chr9:115851400-115852200	Weak transcription	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links